Is Summit Therapeutics, Inc. technically bullish or bearish?
2025-10-07 12:22:47As of 3 October 2025, the technical trend for Summit Therapeutics, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD is bearish and the monthly MACD is mildly bearish. The Bollinger Bands show a mixed signal with the weekly being mildly bearish and the monthly bullish. Overall, the Dow Theory suggests a mildly bullish trend on the weekly timeframe, but no trend on the monthly. In terms of performance, the stock has outperformed the S&P 500 on a weekly basis with a return of 4.68% compared to 1.09%, but it has underperformed over the past month with a return of -14.74% against the S&P 500's 4.15%. Year-to-date, the stock shows a strong return of 24.12%, exceeding the S&P 500's 14.18%. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and the weekly Dow Theory....
Read MoreIs Summit Therapeutics, Inc. technically bullish or bearish?
2025-10-06 12:12:56As of 3 October 2025, the technical trend for Summit Therapeutics, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly and monthly MACD and KST readings are mildly bearish. The Bollinger Bands show a bullish signal on the monthly timeframe, contrasting with the weekly mildly bearish indication. Overall, the Dow Theory suggests a mildly bullish trend on the weekly basis, but no trend on the monthly. In terms of performance, the stock has outperformed the S&P 500 over the past week and year-to-date, with returns of 2.29% and 20.09% respectively, while it lagged behind the index over the past month and year. The current technical stance is mildly bullish, driven primarily by the daily moving averages and the Dow Theory....
Read MoreIs Summit Therapeutics, Inc. technically bullish or bearish?
2025-10-05 11:58:04As of 3 October 2025, the technical trend for Summit Therapeutics, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and KST are both mildly bearish. The Bollinger Bands show a bullish signal on the monthly timeframe, which contrasts with the mildly bearish indicators on the weekly timeframe. Overall, the mixed signals suggest a cautious bullish outlook. In terms of performance, the stock has outperformed the S&P 500 over the past week with a return of 2.29% compared to the S&P 500's 1.09%, but it has underperformed over the past month with a return of -8.89% versus the S&P 500's 4.15%. Year-to-date, the stock has returned 20.09%, outperforming the S&P 500's 14.18%....
Read MoreIs Summit Therapeutics, Inc. technically bullish or bearish?
2025-09-23 11:21:27As of 19 September 2025, the technical trend for Summit Therapeutics, Inc. has changed from mildly bullish to sideways. The current technical stance is neutral, with a mix of indicators showing mild bearishness in the weekly and monthly MACD, KST, and Bollinger Bands, while the daily moving averages indicate a mildly bullish trend. The Dow Theory shows a mildly bullish stance on the monthly timeframe but no trend on the weekly. In terms of performance, the stock has underperformed the S&P 500 over the past month and year, with returns of -27.10% and -21.69% respectively, compared to the S&P 500's 3.95% and 16.64%. However, it has significantly outperformed the benchmark over the 3-year and 5-year periods, with returns of 1491.67% and 482.32%....
Read MoreIs Summit Therapeutics, Inc. technically bullish or bearish?
2025-09-22 18:07:25As of 19 September 2025, the technical trend for Summit Therapeutics, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD is mildly bearish on both weekly and monthly timeframes, while the Bollinger Bands show a bearish weekly signal but a mildly bullish monthly signal. Moving averages indicate a mildly bullish daily trend, contrasting with the weekly KST and OBV, both of which are mildly bearish. In terms of performance, the stock has underperformed against the S&P 500 over the past month and year, with returns of -25.48% and -18.44%, respectively, compared to the S&P's 3.95% and 16.64%. However, it has significantly outperformed over the 3-year and 5-year periods, with returns of 1448.36% and 458.88%, respectively....
Read MoreIs Summit Therapeutics, Inc. technically bullish or bearish?
2025-09-20 20:02:29As of 27 August 2025, the technical trend for Summit Therapeutics, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by daily moving averages indicating mild bullishness, while the weekly and monthly MACD and KST are mildly bearish. Bollinger Bands show a mixed signal with weekly mildly bearish and monthly mildly bullish. Dow Theory indicates a mildly bullish trend on the monthly timeframe. In terms of performance, the stock has outperformed the S&P 500 over the past week with a return of 3.39% compared to 1.05%, but it has underperformed over the past month and year....
Read More





